83P The Immune-related adverse event (IRAE) Likelihood Score (ILS) identifies 'pure' IRAEs strongly associated with outcome in a phase I-II trial population
- Resource Type
- Source
- Immuno-Oncology and Technology. 16:100187
- Subject
Oncology Immunology and Allergy - Language
- ISSN
- 2590-0188